Clinical trial
Post-Marketing Surveillance of Bravonto in Korea
NCT01802359 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Surveillance of Bravonto in Korea
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 7, 2011
- Completion date
- May 31, 2012
- Enrollment
- 379 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.